Artificial Intelligence brings a number of advantages when it comes to health technology assessment (HTA) evaluations and pricing and reimbursement negotiations, according to speakers at the online World Evidence, Pricing and Access Congress 2021. AI systems can help companies build value propositions, differentiate their products and provide rapid answers to questions on the data from HTA bodies, they said.
“AI in the most simplified sense is an automation of a human cognitive task,” said Matthew Michelson, president of Genesis...








